MERTK levels were undetectable in normal resting B and T cells but in clinical samples a significant number of pediatric B-ALL patients had ectopic expression of MERTK and almost half of T-ALL had expression, with the early-stage T-ALL most likely to express [11]. This evidence concerns the gene MERTK and precursor B-cell acute lymphoblastic leukemia.